Kapil Dhingra
Director · 2 filings · Latest: Jun 26, 2026
Black Diamond Therapeutics, Inc.
Replimune Group, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
REPL | Kapil Dhingra | — | Dec 9, 2025 | Proposed Sale | $10.38 | 3,164 | $32.8K | — |